HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.

Abstract
To our knowledge, Sex-determining Region Y box 9 (SOX9) has been in connection with a wide range of human cancers. Nevertheless, there remains uncertainty regarding SOX9's role in metastasizing ovarian cancer. In our study, SOX9 was investigated in relation to tumor metastasis in ovarian cancer as well as its potential molecular mechanisms. First, we exhibited an apparent higher expression of SOX9 in ovarian cancer tissues and cells than in normative ones, and the prognosis of patients whose SOX9 levels were high was markedly lower than that of patients whose SOX9 levels were low. Besides, highly expressed SOX9 was correlated with high grade serous carcinoma, poor tumor differentiation, high serum CA125 and lymph node metastasis. Second, SOX9 knockdown exhibited striking inhibition of the migration and invasive ability of ovarian cancer cells, whereas SOX9 overexpression had an inverse role. At the same time, SOX9 could promote ovarian cancer intraperitoneal metastasis in a nude mice in the vivo. In a similar way, SOX9 knockdown dramatically decreased the expression of nuclear factor I-A (NFIA), β-catenin as well as N-cadherin but had an increased in E-cadherin expression, as opposed to the results when SOX9 was overexpressed. Furthermore, NFIA silencing inhibited the expression of NFIA, β-catenin and N-cadherin, in the same way that E-cadherin expression was promoted. In conclusion, this study shows that SOX9 has a promotional effect on human ovarian cancer and that SOX9 promotes the metastasis of tumors by upregulating NFIA and activating on a Wnt/β-catenin signal pathway. SOX9 could be a novel focus for earlier diagnosis, therapy and prospective evaluation in ovarian cancer.
AuthorsRong Lu, Peipei Tang, Di Zhang, Sen Lin, Hong Li, Xian Feng, Meiling Sun, Hong Zhang
JournalPathology, research and practice (Pathol Res Pract) Vol. 248 Pg. 154602 (Aug 2023) ISSN: 1618-0631 [Electronic] Germany
PMID37315400 (Publication Type: Journal Article)
CopyrightCopyright © 2023. Published by Elsevier GmbH.
Chemical References
  • beta Catenin
  • Cadherins
  • NFI Transcription Factors
  • NFIA protein, human
  • SOX9 protein, human
  • SOX9 Transcription Factor
Topics
  • Animals
  • Female
  • Humans
  • Mice
  • beta Catenin (metabolism)
  • Cadherins (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Epithelial-Mesenchymal Transition
  • Gene Expression Regulation, Neoplastic
  • Mice, Nude
  • NFI Transcription Factors (metabolism)
  • Ovarian Neoplasms (pathology)
  • SOX9 Transcription Factor (genetics)
  • Wnt Signaling Pathway

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: